Skip to main navigation Skip to search Skip to main content

Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science